{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:34:24Z","timestamp":1773423264185,"version":"3.50.1"},"reference-count":43,"publisher":"Japanese Society for Dental Materials and Devices","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dent. Mater. J.","Dental Materials Journal"],"published-print":{"date-parts":[[2022,7,25]]},"DOI":"10.4012\/dmj.2021-331","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T22:10:12Z","timestamp":1652911812000},"page":"624-632","source":"Crossref","is-referenced-by-count":6,"title":["Calcium phosphate-adsorbable and acid-degradable carboxylated polyrotaxane consisting of \u03b2-cyclodextrins suppresses osteoclast resorptive activity"],"prefix":"10.4012","volume":"41","author":[{"given":"Yoshihiro","family":"YOSHIKAWA","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"TAMURA","sequence":"additional","affiliation":[{"name":"Department of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"TSUDA","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"DOMAE","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunyao","family":"ZHANG","sequence":"additional","affiliation":[{"name":"Department of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"YUI","sequence":"additional","affiliation":[{"name":"Department of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"IKEO","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"YOSHIZAWA","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Life Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2427","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) K\u00f6n\u00f6nen E, Gursoy M, Gursoy UK. Periodontitis: A multifaceted disease of tooth-supporting tissues. J Clin Med 2019; 8: 1135.","DOI":"10.3390\/jcm8081135"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Miyamoto T, Suda T. Differentiation and function of osteoclasts. Keio J Med 2003; 52: 1-7.","DOI":"10.2302\/kjm.52.1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jimi E, Takakura N, Hiura F, Nakamura I, Hirata-Tsuchiya S. The role of NF-kappaB in physiological bone development and inflammatory bone diseases: Is NF-kappaB inhibition \u201ckilling two birds with one stone\u201d? Cells 2019; 8: 1636.","DOI":"10.3390\/cells8121636"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hienz SA, Paliwal S, Ivanovski S. Mechanisms of bone resorption in periodontitis. J Immunol Res 2015; 2015: 615486.","DOI":"10.1155\/2015\/615486"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Aur\u00e9al M, Machuca-Gayet I, Coury F. Rheumatoid arthritis in the view of osteoimmunology. Biomolecules 2020; 11: 48.","DOI":"10.3390\/biom11010048"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Udagawa N, Koide M, Nakamura M, Nakamichi Y, Yamashita T, Uehara S, <i>et al.<\/i> Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab 2021; 39: 19-26.","DOI":"10.1007\/s00774-020-01162-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yasuda H. RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases. World J Orthop 2013; 4: 207-217.","DOI":"10.5312\/wjo.v4.i4.207"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) V\u00e4\u00e4n\u00e4nen HK, Laitala-Leinonen T. Osteoclast lineage and function. Arch Biochem Biophys 2008; 473: 132-138.","DOI":"10.1016\/j.abb.2008.03.037"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) V\u00e4\u00e4n\u00e4nen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000; 113: 377-381.","DOI":"10.1242\/jcs.113.3.377"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nesbitt SA, Horton MA. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997; 276: 266-269.","DOI":"10.1126\/science.276.5310.266"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998; 13: 581-589.","DOI":"10.1359\/jbmr.1998.13.4.581"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nishijo J, Moriyama S, Shiota S. Interactions of cholesterol with cyclodextrins in aqueous solution. Chem Pharm Bull (Tokyo) 2003; 51: 1253-1257.","DOI":"10.1248\/cpb.51.1253"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE, Rodan GA, <i>et al.<\/i> Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol\/lipoproteins. Cell Death Differ 2004; 11 Suppl 1: S108-118.","DOI":"10.1038\/sj.cdd.4401399"},{"key":"14","unstructured":"14) Santos-Lozano A, Villamandos Garc\u00eda D, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, <i>et al.<\/i> Niemann-Pick disease treatment: a systematic review of clinical trials. Ann Transl Med 2015; 3: 360."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ory DS, Ottinger EA, Farhat NY, King KA, Jiang X, Weissfeld L, <i>et al.<\/i> Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. Lancet 2017; 390: 1758-1768.","DOI":"10.1016\/S0140-6736(17)31465-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Frijlink HW, Visser J, Hefting NR, Oosting R, Meijer DK, Lerk CF. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat. Pharm Res 1990; 7: 1248-1252.","DOI":"10.1023\/A:1015929720063"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Crumling MA, Liu L, Thomas PV, Benson J, Kanicki A, Kabara L, <i>et al.<\/i> Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-beta-cyclodextrin. PLoS One 2012; 7: e53280.","DOI":"10.1371\/journal.pone.0053280"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997; 86: 147-162.","DOI":"10.1021\/js960213f"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ding D, Manohar S, Jiang H, Salvi R. Hydroxypropyl-beta-cyclodextrin causes massive damage to the developing auditory and vestibular system. Hear Res 2020; 396: 108073.","DOI":"10.1016\/j.heares.2020.108073"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Motoyama K, Toyodome H, Onodera R, Irie T, Hirayama F, Uekama K, <i>et al.<\/i> Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated beta-cyclodextrins. Biol Pharm Bull 2009; 32: 700-705.","DOI":"10.1248\/bpb.32.700"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tamura A, Yui N. Threaded macromolecules as a versatile framework for biomaterials. Chem Commun (Camb) 2014; 50: 13433-13446.","DOI":"10.1039\/C4CC03709J"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Harada A, Hashidzume A, Yamaguchi H, Takashima Y. Polymeric rotaxanes. Chem Rev 2009; 109: 5974-6023.","DOI":"10.1021\/cr9000622"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tamura A, Yui N. Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease. Sci Rep 2014; 4: 4356.","DOI":"10.1038\/srep04356"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Tamura A, Yui N. Polyrotaxane-based systemic delivery of beta-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease. J Control Release 2018; 269: 148-158.","DOI":"10.1016\/j.jconrel.2017.11.016"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tamura A, Nishida K, Yui N. Lysosomal pH-inducible supramolecular dissociation of polyrotaxanes possessing acid-labile N-triphenylmethyl end groups and their therapeutic potential for Niemann-Pick type C disease. Sci Technol Adv Mater 2016; 17: 361-374.","DOI":"10.1080\/14686996.2016.1200948"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tamura A, Ohashi M, Yui N. Oligo(ethylene glycol)-modified beta-cyclodextrin-based polyrotaxanes for simultaneously modulating solubility and cellular internalization efficiency. J Biomater Sci Polym Ed 2017; 28: 1124-1139.","DOI":"10.1080\/09205063.2017.1304173"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zhang S, Tamura A, Yui N. Weakly acidic carboxy group-grafted beta-cyclodextrin-threaded acid-degradable polyrotaxanes for modulating protein interaction and cellular internalization. Sci Technol Adv Mater 2021; 22: 494-510.","DOI":"10.1080\/14686996.2021.1935315"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Fenyvesi E, Szeman J, Csabai K, Malanga M, Szente L. Methyl-beta-cyclodextrins: The role of number and types of substituents in solubilizing power. J Pharm Sci 2014; 103: 1443-1452.","DOI":"10.1002\/jps.23917"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ogawa Y, Goda S, Morita S. The effect of methyl-\u03b2-cyclodextrin on the differentiation of RAW264 cells into osteoclasts. Oral Sci Int 2008; 5: 15-23.","DOI":"10.1016\/S1348-8643(08)80002-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Gotoh K, Kariya R, Alam MM, Matsuda K, Hattori S, Maeda Y, <i>et al.<\/i> The antitumor effects of methyl-beta-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts. Biochem Biophys Res Commun 2014; 455: 285-289.","DOI":"10.1016\/j.bbrc.2014.11.006"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Yoshikawa Y, Yoshizawa T, Domae E, Hirai Y, Kamada A, Okazaki T, <i>et al.<\/i> Knockdown of sphingomyelin synthase 2 inhibits osteoclastogenesis by decreasing RANKL expression in mouse primary osteoblasts. Biomed Res 2019; 40: 189-196.","DOI":"10.2220\/biomedres.40.189"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chaigne-Delalande B, Mahfouf W, Daburon S, Moreau JF, Legembre P. CD95 engagement mediates actin-independent and -dependent apoptotic signals. Cell Death Differ 2009; 16: 1654-1664.","DOI":"10.1038\/cdd.2009.111"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas\/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene 2009; 28: 3221-3234.","DOI":"10.1038\/onc.2009.183"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Ayll\u00f3n V, Fleischer A, Cayla X, Garc\u00eda A, Rebollo A. Segregation of Bad from lipid rafts is implicated in the induction of apoptosis. J Immunol 2002; 168: 3387-3393.","DOI":"10.4049\/jimmunol.168.7.3387"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Fulop T, Larbi A, Douziech N, Fortin C, Gu\u00e9rard KP, Lesur O, <i>et al.<\/i> Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004; 3: 217-226.","DOI":"10.1111\/j.1474-9728.2004.00110.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Motoyama K, Kameyama K, Onodera R, Araki N, Hirayama F, Uekama K, <i>et al.<\/i> Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells. Eur J Pharm Sci 2009; 38: 249-261.","DOI":"10.1016\/j.ejps.2009.07.010"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Matsui H, Tamura A, Osawa M, Tonegawa A, Arisaka Y, Matsumura M, <i>et al.<\/i> Scavenger receptor A-mediated targeting of carboxylated polyrotaxanes to macrophages and the impacts of supramolecular structure. Macromol Biosci 2018; 18: e1800059.","DOI":"10.1002\/mabi.201800059"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-1508.","DOI":"10.1126\/science.289.5484.1504"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Nishida K, Tamura A, Yui N. ER stress-mediated autophagic cell death induction through methylated beta-cyclodextrins-threaded acid-labile polyrotaxanes. J Control Release 2018; 275: 20-31.","DOI":"10.1016\/j.jconrel.2018.02.010"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ooya T, Eguchi M, Ozaki A, Yui N. Carboxyethylester-polyrotaxanes as a new calcium chelating polymer: Synthesis, calcium binding and mechanism of trypsin inhibition. Int J Pharm 2002; 242: 47-54.","DOI":"10.1016\/S0378-5173(02)00139-4"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Baek JM, Kim JY, Jung Y, Moon SH, Choi MK, Kim SH, <i>et al.<\/i> Mollugin from Rubea cordifolia suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis and bone resorbing activity in vitro and prevents lipopolysaccharide-induced bone loss in vivo. Phytomedicine 2015; 22: 27-35.","DOI":"10.1016\/j.phymed.2014.10.008"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Nakamura I, Takahashi N, Jimi E, Udagawa N, Suda T. Regulation of osteoclast function. Mod Rheumatol 2012; 22: 167-177.","DOI":"10.3109\/s10165-011-0530-8"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Endo Y, Kumamoto H, Nakamura M, Sugawara S, Takano-Yamamoto T, Sasaki K, <i>et al.<\/i> Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Biol Pharm Bull 2017; 40: 739-750.","DOI":"10.1248\/bpb.b16-01020"}],"container-title":["Dental Materials Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/dmj\/41\/4\/41_2021-331\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T05:13:38Z","timestamp":1659158018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/dmj\/41\/4\/41_2021-331\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4012\/dmj.2021-331","relation":{},"ISSN":["0287-4547","1881-1361"],"issn-type":[{"value":"0287-4547","type":"print"},{"value":"1881-1361","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"article-number":"2021-331"}}